天美传媒

Insights in Gynecologic Oncology
天美传媒 Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 天美传媒 Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

天美传媒 Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

James P. Patel

Senior Researcher, Institute for Precision Cancer Research, Chicago, Israel
Publications

Role of PARP Inhibitors in Ovarian Cancer

Ovarian cancer, a leading cause of gynecologic cancer mortality, is characterized by DNA repair deficiencies in up to 50% of cases, particularly in BRCA-mutated and homologous recombination-deficient (HRD) tumors. Poly (ADPribose) polymerase (PARP) inhibitors, such as olaparib, niraparib, and rucaparib, exploit these vulnerabilities, offering signi... Read More»

James P. Patel

: Current Trends Gynecol Oncol 2025, 10:260

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top Connection closed successfully.